Although providers might turn to PCSK9 inhibitors to treat patients at risk for atherosclerotic cardiovascular disease or familial hypercholesterolemia for whom statins do not work, the initial denial rate for this therapy can be very high.
Given the chance to suggest a healthcare policy change to lawmakers, Michael Griffin, president and CEO of Daughters of Charity Services, would recommend making Medicaid available to all Americans. Griffin said this would reduce cost while greatly expanding access.
This week, the top managed care news included the Congressional Budget Office's new score for the American Health Care Act; the White House released its fiscal year 2018 budget; and a cancer drug approval that is a first for the FDA.
Based on the results of the phase 2 ZUMA-1 trial in patients with refractory non-Hodgkin lymphoma, Kite Pharma has submitted for, and received, a priority review for its chimeric antigen receptor (CAR)-T cell treatment, axicabtagene ciloleucel.
A new study published in Diabetes Care investigates ways to prevent driving accidents among patients with type 1 diabetes, who may be at higher risk of having such mishaps.
Few people have adequate savings for long-term care, and most assume they will care for relatives and rely on family for their own care. A survey from the Associated Press and the NORC Center for Public Affairs Research found support for family leave policies across members of both parties.
A panel discussion on biosimilars at the ISPOR 22nd Annual International Meeting compared the progress in the United States with Europe, which has had a 10-year head start on the market.
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium